glp-1 obesity drug market news today A $60 billion industry just found its next growth lever. 💊 With the expiry of a key patent on March 20, 2026, Indian pharma majors are launching generic weight-loss and diabetes drugs GLP-1 Market Trends and Global

In laboratory environments, GHRP-2 is widely studied for its interaction with the growth hormone secretagogue receptor (GHS-R), also known as the ghrelin receptor

Nutraceuticals as modulators of autophagy: relevance in Parkinson's disease

In the early 1900s, with the advent of new medical therapies and disease perspectives, novel strategies were employed to promote weight loss including thyroid hormone supplementation, and later, amphetamines [1]

Leveraging precision medicine, pharmacogenomics, and validated monitoring tools will be essential in minimizing liver injury and enhancing outcomes in systemic psoriasis care